RU2003123647A - METHOD FOR INCREASING SPECIFIC ACTIVITY OF IGG CLASS ANTIBODIES - Google Patents

METHOD FOR INCREASING SPECIFIC ACTIVITY OF IGG CLASS ANTIBODIES Download PDF

Info

Publication number
RU2003123647A
RU2003123647A RU2003123647/15A RU2003123647A RU2003123647A RU 2003123647 A RU2003123647 A RU 2003123647A RU 2003123647/15 A RU2003123647/15 A RU 2003123647/15A RU 2003123647 A RU2003123647 A RU 2003123647A RU 2003123647 A RU2003123647 A RU 2003123647A
Authority
RU
Russia
Prior art keywords
specific activity
igg class
class antibodies
increasing specific
increasing
Prior art date
Application number
RU2003123647/15A
Other languages
Russian (ru)
Other versions
RU2254874C2 (en
Inventor
Тимирбек Газизович Нигматуллин (RU)
Тимирбек Газизович Нигматуллин
Рамил Гайсаровна Атангулова (RU)
Рамиля Гайсаровна Атангулова
Азамат Габдельахатович Исрафилов (RU)
Азамат Габдельахатович Исрафилов
Елена Викторовна Мостовска (RU)
Елена Викторовна Мостовская
Римма Сабировна Шафиева (RU)
Римма Сабировна Шафиева
Original Assignee
Федеральное государственное унитарное предпри тие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "МИКРОГЕН" МЗ РФ (RU)
Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "МИКРОГЕН" МЗ РФ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное унитарное предпри тие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "МИКРОГЕН" МЗ РФ (RU), Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "МИКРОГЕН" МЗ РФ filed Critical Федеральное государственное унитарное предпри тие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "МИКРОГЕН" МЗ РФ (RU)
Priority to RU2003123647/15A priority Critical patent/RU2254874C2/en
Publication of RU2003123647A publication Critical patent/RU2003123647A/en
Application granted granted Critical
Publication of RU2254874C2 publication Critical patent/RU2254874C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Claims (1)

Способ повышения специфической активности антител IgG класса, представляющий собой криорадиационную обработку иммуноглобулин G-содержащих фракций в дозах 5-50 кГр при температуре минус 20-196°С.A method of increasing the specific activity of IgG class antibodies, which is a cryoradiation treatment of immunoglobulin G-containing fractions in doses of 5-50 kGy at a temperature of minus 20-196 ° C.
RU2003123647/15A 2003-07-25 2003-07-25 Method for enhancing specific activity of antibody of igg class RU2254874C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003123647/15A RU2254874C2 (en) 2003-07-25 2003-07-25 Method for enhancing specific activity of antibody of igg class

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003123647/15A RU2254874C2 (en) 2003-07-25 2003-07-25 Method for enhancing specific activity of antibody of igg class

Publications (2)

Publication Number Publication Date
RU2003123647A true RU2003123647A (en) 2005-02-27
RU2254874C2 RU2254874C2 (en) 2005-06-27

Family

ID=35285865

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003123647/15A RU2254874C2 (en) 2003-07-25 2003-07-25 Method for enhancing specific activity of antibody of igg class

Country Status (1)

Country Link
RU (1) RU2254874C2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714350A (en) * 1992-03-09 1998-02-03 Protein Design Labs, Inc. Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
US5367058A (en) * 1993-08-25 1994-11-22 Becton, Dickinson And Company Modified antibodies with increased affinity

Also Published As

Publication number Publication date
RU2254874C2 (en) 2005-06-27

Similar Documents

Publication Publication Date Title
ATE417037T1 (en) DIARYLUREA DERIVATIVES SUITABLE FOR THE TREATMENT OF PROTEIN KINASE-DEPENDENT DISEASES
CY2012019I1 (en) HUMAN MONOCLONAL ANTIBODIES AGAINST CD20
ATE549033T1 (en) THERAPEUTIC HUMAN MONOCLONAL ANTI-IL-1R1 ANTIBODY
LTPA2017040I1 (en) Antibodies to CD38 antigen for the treatment of multiple myeloma
DK1406656T3 (en) Methods for administering anti-TNF alpha antibodies
EP1633785A4 (en) Human monoclonal antibodies against bacillusanthracis protective antigen
NL1026892A1 (en) 11.8 Naphthyridin-2-ones and related compounds for the treatment of schizophrenia.
DK1578397T3 (en) Human monoclonal antibodies against CD25
DE60329983D1 (en) WAXESESYNTHASE DNA SEQUENCE, PROTEIN AND USES THEREOF
ATE464374T1 (en) ASSAY FOR THE RAPID DETECTION OF HUMAN ACTIVATED PROTEIN C AND HIGHLY SPECIFIC MONOCLONAL ANTIBODIES AGAINST IT
DE60235553D1 (en) ANTIGENBINDING DOMAIN FROM FISH
NO20054078D0 (en) Human antibodies specific for Interleukin 15 (IL15).
IL149820A0 (en) Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
DE60226036D1 (en) ANTIBODY THAT DETERMINES THE GM1-GANGLIOSID-BOUND AMYLOID-B PROTEIN AND DNA THAT CODES FOR THIS ANTIBODY
DK1366067T3 (en) EXPRESSION TECHNOLOGY FOR PROTEINS CONTAINING A HYBRID ISOTYPE ANTIBODY UNIT
WO2003068821A3 (en) Anti-cd20 antibodies and fusion proteins thereof and methods of use
WO2005103081A3 (en) Human monoclonal antibodies against cd20
BRPI0413495A (en) prion-specific peptide reagents and their uses
DK1542725T3 (en) PROCEDURE FOR HUMANIZING IMMUNE SYSTEM MOLECULES
WO2004094473A3 (en) Humanized antibodies to interferon alpha receptor-1 (ifnar-1)
WO2004035742A3 (en) Sets of digital antibodies directed against short epitopes, and methods using same
ECSP066432A (en) THERAPEUTIC LINK MOLECULES
NL1026203A1 (en) Compounds useful for the treatment of diseases.
WO2007027805A3 (en) Method for generating anti-variable region monoclonal antibodies
ITTO20020340A1 (en) LOCATION OF THE HER2 RECEPTOR BY HUMANIZED BIOTINYLATE ANTIBODY.

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20180716

PD4A Correction of name of patent owner